Over the past decade, a troubling pattern has emerged in how breast cancer is treated.

    The focus is on a specific type of breast cancer, one that is ERBB2-positive.

    This type of cancer is known for its aggressive nature.

    The treatment for this type of cancer is called ERBB2-targeted therapy.

    This therapy has been a game-changer for many patients.

    However, not everyone has equal access to this life-saving treatment.

    The issue is stark when looking at older women, those aged 50 and above.

    Black women in this age group are less likely to receive ERBB2-targeted therapy compared to their white counterparts.

    This disparity is not about biology but about access and opportunity.

    It raises serious questions about fairness in healthcare.

    The problem is not just about getting the treatment. It is also about the quality of care.

    Access to the latest treatments can mean the difference between life and death.

    It is crucial to understand why these disparities exist.

    Is it due to socioeconomic factors? Is it because of biases in the healthcare system?

    These are questions that need answers.

    The data shows a clear gap in treatment rates.

    This gap is not small.

    It is significant and worrying.

    It highlights a systemic issue that needs to be addressed.

    The goal should be to ensure that all women, regardless of their race or ethnicity, have equal access to the best possible care.

    It is not just about providing treatment.

    It is about providing hope and a chance at a better life.

    The healthcare system needs to do better.

    It needs to ensure that every woman has access to the care she needs.

    It is a matter of fairness and justice.

Unequal Care: Breast Cancer Treatment Gaps

Actions